SHINE submits application for isotope plant to NRC

03/31/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies in Monona, Wis., said it has submitted an application to the Nuclear Regulatory Commission for the establishment of a medical isotope facility in Janesville, Wis., that will produce molybdenum-99, the precursor isotope to technetium-99m. The company said it anticipates the review of its plan will take 18 months. SHINE wants to start production by 2015 and projects to create at least 150 jobs.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX